Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Resverlogix : IIROC Trading Halt - RVX

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:32pm CET

TORONTO, Oct. 13, 2017 /CNW/ - The following issues have been halted by IIROC:

Company: Resverlogix Corp.

TSX Symbol: RVX (all issues)

Reason: Pending News

Halt Time (ET): 9:16: AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
02/12RESVERLOGIX : Highlights key accomplishments and 2018 targets
AQ
02/08Resverlogix Highlights Key Accomplishments and 2018 Targets
GL
01/11Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMAC..
GL
01/09RESVERLOGIX : and Medison Pharma Ltd. Announce Strategic Licensing Agreement
AQ
01/08RESVERLOGIX : and Medison Pharma Ltd. Announce Strategic Licensing Agreement
GL
01/08RESVERLOGIX AND MEDISON PHARMA LTD. : Alliance to focus on regulatory approval,..
AQ
01/08Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
GL
2017RESVERLOGIX : Streetwise Reports Examines How One Biotech Receives `Major Endors..
AQ
2017RESVERLOGIX : Announces filing of quarterly financial statements and management'..
AQ
2017RESVERLOGIX : Announces voting results from the 2017 annual meeting of sharehold..
AQ
More news
News from SeekingAlpha
02/13Resverlogix (RVXCF) Presents At BIO CEO & Investor Conference - Slideshow 
02/12FDA accepts Amicus' migalastat NDA for Fabry; action date August 13 
01/11Resverlogix to add U.S. sites to late-stage study of RVX-208 in T2D 
2017YOUR DAILY PHARMA SCOOP : Aclaris Gets Approval, Egalet Surges, Alnylam Gains As.. 
2017Resverlogix reports Q2 results 
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Technical analysis trends RESVERLOGIX CORP.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.-25.12%214
CELLTRION, INC.--.--%34 853
IQVIA HOLDINGS INC2.41%20 749
LONZA GROUP-6.57%19 479
INCYTE CORPORATION-9.71%17 877
NEKTAR THERAPEUTICS39.74%13 613